Form 990 for tax year 2024
Filed by ALTERNATIVES FOR RESEARCH AND DEVELOPMENT FOUNDATION.
Totals
- Total revenue
- $2,129,417
- Total expenses
- $834,489
- Contributions and grants received
- $1,233,029
- Grants paid
- $413,605
- Program service revenue
- $0
- Investment income
- $896,388
- Other revenue
- $0
- Total assets, end of year
- $16,848,676
- Total liabilities, end of year
- $44,137
- Net assets or fund balances, end of year
- $16,804,539
- Program services expenses (Part IX)
- $648,559
- Management and general expenses
- $182,051
- Fundraising expenses
- $3,879
- Program service expenses (Part III)
- $648,559
Program services were 77.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$1,233,029
-
3 · Investment income
total $241,189 · excluded $241,189
-
7a · Gross sales of assets other than inventory
securities $3,073,648
-
7b · Less cost or other basis and sales expenses
securities $2,418,449
-
7c · Gain or loss
securities $655,199
-
7d · Net gain or loss
total $655,199 · excluded $655,199
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $314,914 · program services $314,914
-
2 · Grants to domestic individuals
total $10,000 · program services $10,000
-
3 · Grants to foreign organizations and individuals
total $88,691 · program services $88,691
-
5 · Compensation of officers, directors and key employees
total $20,000 · program services $20,000
-
7 · Other salaries and wages
total $19,922 · program services $7,279 · management and general $10,055 · fundraising $2,588
-
9 · Other employee benefits
total $11,546 · program services $7,291 · management and general $3,255 · fundraising $1,000
-
10 · Payroll taxes
total $3,235 · program services $2,092 · management and general $902 · fundraising $241
-
11b · Fees: legal
total $4,930 · management and general $4,930
-
11c · Fees: accounting
total $18,725 · management and general $18,725
-
11f · Fees: investment management
total $142,930 · management and general $142,930
-
11g · Fees: other
total $149,817 · program services $149,651 · management and general $132 · fundraising $34
-
13 · Office expenses
total $9,508 · program services $9,098 · management and general $394 · fundraising $16
-
16 · Occupancy
total $18,971 · program services $18,338 · management and general $633
-
19 · Conferences, conventions and meetings
total $18,919 · program services $18,919
-
22 · Depreciation, depletion and amortization
total $600 · program services $600
-
23 · Insurance
total $81 · program services $61 · management and general $20
-
24a · Other expenses: RESEARCH AND INFORMATIO
total $1,614 · program services $1,582 · management and general $32
-
24b · Other expenses: POSTAGE AND SHIPPING
total $86 · program services $43 · management and general $43
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $80,052 · end of year $46,218
-
2 · Savings and temporary cash investments
beginning of year $1,044,307 · end of year $2,260,339
-
4 · Accounts receivable
beginning of year $18,075 · end of year $18,069
-
9 · Prepaid expenses and deferred charges
beginning of year $3,358 · end of year $3,250
-
10a · Land, buildings and equipment: cost or other basis
$12,396
-
10b · Land, buildings and equipment: accumulated depreciation
$11,496
-
10c · Land, buildings and equipment, net
beginning of year $1,500 · end of year $900
-
11 · Investments: publicly traded securities
beginning of year $12,634,377 · end of year $14,050,290
-
15 · Other assets
beginning of year $423,277 · end of year $469,610
-
17 · Accounts payable and accrued expenses
beginning of year $7,496 · end of year $3,677
-
25 · Other liabilities
beginning of year $8,682 · end of year $40,460
-
27 · Net assets without donor restrictions
beginning of year $13,229,485 · end of year $14,624,283
-
28 · Net assets with donor restrictions
beginning of year $959,283 · end of year $2,180,256
Mission and programs · 2024
Mission
THE MISSION OF THE ARDF IS TO FUND AND PROMOTE THE DEVELOPMENT, VALIDATION AND ADOPTION OF NON-ANIMAL METHODS IN BIOMEDICAL RESEARCH, PRODUCT TESTING, AND EDUCATION.
Activities or mission (Part I)
ARDF PROMOTES AND DEVELOPS ALTERNATIVE SCIENTIFIC SOLUTIONS TO THE PROBLEM OF ANIMAL TESTING.
-
THE "ANNUAL OPEN" GRANT PROGRAM FUNDS INNOVATIVE ALTERNATIVE METHODS TO REDUCE OR REPLACE ANIMAL USE IN RESEARCH AND TESTING.IN 2024, ARDF FUNDED THE FOLLOWING PROJECTS FOR SCIENTIFIC RESEARCH: 1) NEW HUMAN MODELS FOR THE STUDY OF ATRIAL FIBRILLATION; 2) IN VITRO TRANSPLANTATION MODELING USING INDUCED PLURIPOTENT STEM CELL-DERIVED GRAFTS; 3) MODELING HUMAN BONE MARROW ENGRAFTMENT AND HEMATOPOIESIS IN A MICRO-FLUIDIC PLATFORM; 4) A HUMAN BLADDER MODEL TO DECIPHER HOST-UROPATHOGEN INTERACTIONS FROM TISSUE TO SINGLE-CELLS; 5) COMPUTATIONAL DISCOVERY OF LONG NON-CODING RNAS AS NOVEL RELAPSE RISK BIOMARKERS FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA; 6) A HUMAN PRECISION-CUT LUNG SLICE-BASED PLATFORM FOR FIBROTIC DRUG DISCOVERY; 7) DEVELOPING HUMAN CELL-BASED GLIOBLASTOMA MODELS FREE FROM ANIMAL DERIVATIVES; 8) MODELING JOINT PAIN USING AN ANIMAL-FREE SYSTEM ON A CHIP; 9) DEVELOPING A MODEL TO STUDY LIPID BODIES AND SEX-DEPENDENT IMMUNE RESPONSES IN HUMAN MONOCYTE-DERIVED MACROPHAGES; 10) REGULATORY T CELL SUPPRESSIVE FUNCTIONS IN MIGRAINE.THIS YEAR'S FOCUS ON DEVELOPING MODELS TO AID DEVELOPMENT OF TREATMENTS UNDERSCORES THE TREMENDOUS POTENTIAL OF IN VITRO MODELS FOR BIOMEDICAL RESEARCH. BY SUPPORTING RESEARCH TO DEVELOP ALTERNATIVE, ANIMAL-FREE MODELS, ARDF CONTINUES TO ADVANCE BOTH ANIMAL WELFARE AND HUMAN HEALTH.ARDF ALSO ADDED ITS EXPERTISE TO POLICY DISCUSSIONS OF ADVANCING ALTERNATIVE METHODS. FOR EXAMPLE, IN 2024, ARDF PRESIDENT SUE LEARY SERVED ON THE SCIENTIFIC ADVISORY COMMITTEE ON ALTERNATIVE TOXICOLOGICAL METHODS TO A DEPARTMENT OF THE NATIONAL INSTITUTES OF HEALTH. ARDF AWARDED THE WILLIAM AND ELEANOR CAVE AWARD TO ANNA LOWIT, PHD, FOR HER CAREER ACCOMPLISHMENTS IN IMPLEMENTING ALTERNATIVE APPROACHES IN CHEMICAL AND PESTICIDE TESTING. ARDF SPONSORED SCIENTIFIC MEETINGS, AND EDUCATION AND OUTREACH ON ALTERNATIVE METHODS TO ACCELERATE UNDERSTANDING AND COLLABORATION.
Expenses $648,559 · Grants $413,605
As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Sue A LearySUE A LEARY
PRESIDENT
- Total calculated
- $94,790
- From this org
- $20,000
- From related orgs
- $68,260
- Other
- $6,530
- Hours/week
- 12 + 35 related
-
Luke KleinLUKE KLEIN
BOARD MEMBER
- Total calculated
- $105,701
- From this org
- $0
- From related orgs
- $92,215
- Other
- $13,486
- Hours/week
- 0.5 + 35 related
-
Nadia S AdawiNADIA S ADAWI
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5 + 0.5 related
-
Robert FinnROBERT FINN
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5 + 0.5 related
-
Francis Krafchik Deceased In 2024FRANCIS KRAFCHIK DECEASED IN 2024
BOARD MEMBER
- Total calculated
- $0
- Hours/week
- 0.5 + 0.5 related
-
Joseph LudwigJOSEPH LUDWIG
VICE PRESIDENT
- Total calculated
- $0
- Hours/week
- 0.5 + 1 related
-
Aaron McIntyreAARON MCINTYRE
TREASURER
- Total calculated
- $0
- Hours/week
- 0.5 + 1 related
-
Denise CowieDENISE COWIE
SECRETARY
- Total calculated
- $0
- Hours/week
- 0.5 + 1 related
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
UNIVERSITY OF MASSACHUSETTS CHAN MEDICAL SCHOOL
$40,000
DR. TIEN-CHAN HSIEH RESEARCH GRANT COMPUTATIONAL DISCOVERY OF LONG NON-CODING RNAS AS NOVEL RELAPSE RISK BIOMARKERS FOR PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
-
$40,000
DR. AITOR AGUIRRE RESEARCH GRANT NEW HUMAN MODELS FOR THE STUDY OF ATRIAL FIBRILLATION
-
DR. WONJAE LEE RESEARCH GRANT DEVELOPING HUMAN CELL-BASED GLIOBLASTOMA MODELS FREE FROM ANIMAL DERIVATIVES
-
UNIVERSITY OF WASHINGTON
$40,000
DR. LAURA CRISA RESEARCH GRANT MODELING HUMAN BONE MARROW ENGRAFTMENT AND HEMATOPOIESIS IN A MICRO-FLUIDIC PLATFORM
-
UNIVERSITY OF WISCONSIN-MADISON
$40,000
DR. MATTHEW BROWN RESEARCH GRANT IN VITRO TRANSPLANTATION MODELING USING INDUCED PLURIPOTENT STEM CELL-DERIVED GRAFTS
-
DR. RAMASWAMY KRISHNAN RESEARCH GRANT A HUMAN PRECISION-CUT LUNG SLICE-BASED PLATFORM FOR FIBROTIC DRUG DISCOVERY
-
RUSH UNIVERSITY MEDICAL CENTER
$39,996
DR. RACHEL MILLER RESEARCH GRANT MODELING JOINT PAIN USING AN ANIMAL-FREE SYSTEM ON A CHIP
-
UNIVERSITY OF NORTHERN IOWA
$17,915
DR. NILDA RODRIGUEZ RESEARCH GRANT - DEVELOPING A MODEL TO STUDY LIPID BODIES AND SEX-DEPENDENT IMMUNE RESPONSES IN HUMAN MONOCYTE-DERIVED MACROPHAGES
-
SPONSORHIP OF ASCCT MEETING EVENT
Activities outside the United States
From Schedule F of this return, as filed.
- Offices (line 3c)
- 0
- Employees, agents and contractors (line 3c)
- 1
- Expenditures and investments (line 3c)
- $220,301
At most 25 lines of each part are listed here. Schedule F names no grantee, so each line is a region and its money.
Activities by region (Part I)
| Region | Offices | Employees | Activity | Specific services | Expenditures |
|---|---|---|---|---|---|
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 1 | PROGRAM SERVICES | GRANT PROGRAM MANAGEMENT | $131,610 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | PROGRAM SERVICES | RESEARCH GRANTS | $88,691 |
Grants to organizations, by region (Part II)
The purpose of each grant is not shown.
| Region | Cash grants | Manner of disbursement | Noncash assistance | Noncash description | Valuation |
|---|---|---|---|---|---|
| BRAZIL | $20,000 | WIRE TRANSFER | $0 | — | — |
| SWITZERLAND | $39,000 | WIRE TRANSFER | $0 | — | — |
| FRANCE | $29,691 | WIRE TRANSFER | $0 | — | — |
- Transferred property to a foreign corporation during the year (line 1)
- No
- Had an interest in a foreign trust (line 2)
- No
- Owned an interest in a foreign corporation (line 3)
- No
- Was a shareholder of a passive foreign investment company or qualified electing fund (line 4)
- No
- Owned an interest in a foreign partnership (line 5)
- No
- Had operations in or related to a boycotting country (line 6)
- No
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
AMERICAN ANTI-VIVISECTION SOCIETY
501(C)(3) · EDUCATE THE PUBLIC ON PROBLEMS OF ANIMAL EXPERIMENTATION · PA
Directly controlled by NONE
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 23 April 2025
- IRS schema version
- 2024v5.1
- Source object
- 202541269349301874
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.